Adrenal tumors: How to establish malignancy?

[1]  H. Hedeland,et al.  On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. , 2009, Acta medica Scandinavica.

[2]  W. Habscheid,et al.  [Puncture track metastasis after ultrasound-guided fine-needle puncture biopsy. A rare complication?]. , 2008, Deutsche medizinische Wochenschrift.

[3]  G. Braunstein.  Management of the Clinically Inapparent Adrenal Mass , 2004 .

[4]  G. Braunstein,et al.  Management of the Clinically Inapparent Adrenal Mass (Incidentaloma) , 2003, Annals of Internal Medicine.

[5]  M. Bergström,et al.  11C-metomidate PET imaging of adrenocortical cancer , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  C. Nies,et al.  High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. , 2003, Human pathology.

[7]  T. Mussack,et al.  Laparoscopic lateral adrenalectomy versus open posterior adrenalectomy for the treatment of benign adrenal tumors , 2003, Surgical Endoscopy And Other Interventional Techniques.

[8]  D. Goldstein,et al.  Diagnostic Localization of Pheochromocytoma , 2002 .

[9]  M. Bergström,et al.  The Role of PET in Localization of Neuroendocrine and Adrenocortical Tumors , 2002, Annals of the New York Academy of Sciences.

[10]  M. Korobkin,et al.  Imaging of adrenal incidentalomas: current status. , 2002, AJR. American journal of roentgenology.

[11]  H. Köstler,et al.  2D-SPLASH-Spektroskopie zur Bestimmung des Fett/Wasser-Verhältnisses in der Rotatorenmanschette , 2002 .

[12]  Q. Duh,et al.  Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. , 2002, Archives of surgery.

[13]  H. Bonjer,et al.  The value of plasma markers for the clinical behaviour of phaeochromocytomas. , 2002, European journal of endocrinology.

[14]  L. Fig,et al.  Functional scintigraphy of the adrenal gland. , 2002, European journal of endocrinology.

[15]  L. Thompson.  Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases , 2002, The American journal of surgical pathology.

[16]  Melvyn Korobkin,et al.  Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. , 2002, Radiology.

[17]  C. Cordon-Cardo,et al.  Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  H. Neumann,et al.  Pheochromocytomas: detection with 18F DOPA whole body PET--initial results.. , 2002, Radiology.

[19]  B. Niederle,et al.  How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. , 2002, European journal of radiology.

[20]  L. Brunt.  The positive impact of laparoscopic adrenalectomy on complications of adrenal surgery , 2002, Surgical Endoscopy And Other Interventional Techniques.

[21]  A. Alavi,et al.  18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  F. Angelini,et al.  Fine‐needle aspiration cytology of adrenal masses in noncancer patients , 2001, Cancer.

[23]  Jeffrey E. Lee,et al.  Adrenal cortical carcinoma , 2001, World Journal of Surgery.

[24]  G. Karanikas,et al.  FDG-PET in adrenocortical carcinoma. , 2001, Cancer biotherapy & radiopharmaceuticals.

[25]  J. Doppman,et al.  A "pheo" lurks: novel approaches for locating occult pheochromocytoma. , 2001, The Journal of clinical endocrinology and metabolism.

[26]  Graeme Eisenhofer,et al.  6-[18F]Fluorodopamine Positron Emission Tomographic (PET) Scanning for Diagnostic Localization of Pheochromocytoma , 2001, Hypertension.

[27]  G. Chatellier,et al.  Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. , 2001, The Journal of clinical endocrinology and metabolism.

[28]  M. Kacem,et al.  [Incidentally discovered adrenal masses]. , 2001, La Tunisie medicale.

[29]  P. Manhem,et al.  Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas. , 2001, Journal of internal medicine.

[30]  A. Januszewicz,et al.  Dopamine and Dopa Urinary Excretion in Patients with Pheochromocytoma–Diagnostic Implications , 2001, Blood pressure.

[31]  D. D’amico,et al.  Management of incidentally discovered adrenal masses and risk of malignancy. , 2000, Surgery.

[32]  P R Mueller,et al.  Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. , 2000, Radiology.

[33]  W. Saeger.  Histopathological classification of adrenal tumours , 2000, European journal of clinical investigation.

[34]  I. Francis,et al.  Delayed enhanced CT of lipid-poor adrenal adenomas. , 2000, AJR. American journal of roentgenology.

[35]  A. Fassina,et al.  Fine needle aspiration cytology (FNAC) of adrenal masses , 2000, Cytopathology : official journal of the British Society for Clinical Cytology.

[36]  H. Sasano,et al.  A case of adrenocortical carcinoma associated with recurrence after laparoscopic surgery , 2000, Clinical endocrinology.

[37]  T. Matsuda,et al.  Complications of laparoscopic and retroperitoneoscopic adrenalectomies in 370 cases in Japan: a multi-institutional study. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  P. Paccotti,et al.  The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. , 2000, European journal of endocrinology.

[39]  M. Reincke.  Subclinical Cushing's syndrome. , 2000, Endocrinology and metabolism clinics of North America.

[40]  D. Schteingart.  Management approaches to adrenal incidentalomas. A view from Ann Arbor, Michigan. , 2000, Endocrinology and metabolism clinics of North America.

[41]  W. Young,et al.  Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. , 2000, Endocrinology and metabolism clinics of North America.

[42]  A. Latronico,et al.  Adrenocortical carcinoma , 2000, Cancer.

[43]  G. Arnaldi,et al.  A Survey on Adrenal Incidentaloma in Italy , 2000 .

[44]  J. Rastad,et al.  PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  G. Arnaldi,et al.  A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. , 2000, The Journal of clinical endocrinology and metabolism.

[46]  M. Demeure,et al.  Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation , 1999 .

[47]  C. Fiori,et al.  What is the role of ultrasonography in the follow-up of adrenal incidentalomas? The Gruppo Piemontese Incidentalomi Surrenalici. , 1999, Urology.

[48]  A. Pérez‐Barrios,et al.  Fine‐needle aspiration biopsy of the adrenal glands: A ten‐year experience , 1999, Diagnostic cytopathology.

[49]  B. Niederle,et al.  Characterization of adrenal masses using MR imaging with histopathologic correlation. , 1999, AJR. American journal of roentgenology.

[50]  B. Alfano,et al.  Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. , 1999, AJR. American journal of roentgenology.

[51]  D. Hauri,et al.  Pheochromocytomas: can malignant potential be predicted? , 1999, Urology.

[52]  H. Cramer,et al.  Fine Needle Aspiration Cytology of Benign Adrenal Cortical Nodules , 1998, Acta Cytologica.

[53]  Y. Kubota,et al.  Elevated levels of telomerase activity in malignant pheochromocytoma , 1998, Cancer.

[54]  J. Rastad,et al.  [Differential diagnosis in adrenal gland tumors using PET and 11C-metomidate]. , 1998, Nordisk medicin.

[55]  F. Pattou,et al.  Experience gained from operation of 103 adrenal incidentalomas , 1998, Langenbeck's Archives of Surgery.

[56]  G. Gazelle,et al.  Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. , 1998, AJR. American journal of roentgenology.

[57]  R. Weyant,et al.  Prognostic markers in pheochromocytoma. , 1998, Human pathology.

[58]  D. Szolar,et al.  Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. , 1998, Radiology.

[59]  L. Quint,et al.  CT time-attenuation washout curves of adrenal adenomas and nonadenomas. , 1998, AJR. American journal of roentgenology.

[60]  G. Chrousos,et al.  Extensive personal experience: adrenocortical tumors. , 1997, The Journal of clinical endocrinology and metabolism.

[61]  A. Makowska,et al.  Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients , 1997, Clinical endocrinology.

[62]  L. Quint,et al.  Adrenal adenomas: relationship between histologic lipid and CT and MR findings. , 1996, Radiology.

[63]  E. Outwater,et al.  Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. , 1996, Radiology.

[64]  R. Bellantone,et al.  The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. , 1996, Surgery.

[65]  P. Paccotti,et al.  Different patterns of steroid secretion in patients with adrenal incidentaloma. , 1996, The Journal of clinical endocrinology and metabolism.

[66]  A M Aisen,et al.  Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. , 1995, Radiology.

[67]  R. Kloos,et al.  Incidentally discovered adrenal masses. , 1995, Cancer treatment and research.

[68]  E. Kazerooni,et al.  Percutaneous CT‐Guided Biopsy of Adrenal Masses: Immediate and Delayed Complications , 1995, Journal of computer assisted tomography.

[69]  J. Singer,et al.  MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. , 1995, AJR. American journal of roentgenology.

[70]  F. Camanni,et al.  Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour , 1995, Clinical endocrinology.

[71]  P. Paccotti,et al.  Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas) , 1994, The Journal of clinical endocrinology and metabolism.

[72]  S. Swensen,et al.  Percutaneous adrenal biopsy: review of a 10-year experience. , 1994, Radiology.

[73]  E. Bravo,et al.  Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. , 1994, Endocrine reviews.

[74]  N. Obuchowski,et al.  Metastasis or adenoma? Computed tomographic evaluation of the adrenal mass. , 1994, Cleveland Clinic journal of medicine.

[75]  C. Proye,et al.  Safety of the posterior approach in adrenal surgery: experience in 105 cases. , 1993, Surgery.

[76]  J. Sirén,et al.  Incidentalomas of the adrenal gland: 36 Operated patients and review of literature , 1993, World Journal of Surgery.

[77]  S. Seltzer,et al.  Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. , 1993, Radiology.

[78]  M. Schlumberger,et al.  Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases , 1992, Journal of endocrinological investigation.

[79]  Wadih Ge,et al.  Fine-needle aspiration cytology of the adrenal gland. Fifty biopsies in 48 patients. , 1992 .

[80]  P. Sheedy,et al.  Incidentally discovered adrenal tumors: an institutional perspective. , 1991, Surgery.

[81]  G. Glazer,et al.  Clinical significance of the large adrenal mass , 1991, The British journal of surgery.

[82]  T. Egglin,et al.  Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. , 1991, Radiology.

[83]  L. Medeiros,et al.  Pathologic Features of Prognostic Significance in Adrenocortical Carcinoma , 1989, The American journal of surgical pathology.

[84]  I. Francis.  Distinguishing benign from malignant euadrenal masses , 1988 .

[85]  E. Fishman,et al.  Primary adrenocortical carcinoma: sonographic evaluation with clinical and pathologic correlation in 26 patients. , 1987, AJR. American journal of roentgenology.

[86]  D. Ackery,et al.  A RE‐EVALUATION OF DOPAMINE EXCRETION IN PHAEOCHROMOCYTOMA , 1986, Clinical endocrinology.

[87]  G. Casola,et al.  Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy. , 1986, Radiology.

[88]  B. Yankaskas,et al.  Delayed complications from fine-needle biopsies of solid masses of the abdomen. , 1986, Investigative radiology.

[89]  S. McCorkell,et al.  Fine-needle aspiration of catecholamine-producing adrenal masses: a possibly fatal mistake. , 1985, AJR. American journal of roentgenology.

[90]  H. Slooten,et al.  Morphologic characteristics of benign and malignant adrenocortical tumors , 1985, Cancer.

[91]  N. Orentreich,et al.  Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. , 1984, The Journal of clinical endocrinology and metabolism.

[92]  S. Patel,et al.  Fine needle aspiration cytology of the adrenal gland. , 1984, Acta cytologica.

[93]  L. Weiss.  Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors , 1984, The American journal of surgical pathology.

[94]  N. Samaan,et al.  Adrenal cortical carcinoma a study of 77 cases , 1983, Cancer.

[95]  D. Swanson,et al.  Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms. , 1981, The Journal of clinical endocrinology and metabolism.

[96]  D. Page,et al.  Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. , 1979, American journal of clinical pathology.

[97]  A. Masi,et al.  ADRENAL CORTICAL ADENOMAS AND HYPERTENSION: A CLINICAL PATHOLOGIC ANALYSIS OF 690 CASES WITH MATCHED CONTBOLS AND A REVIEW OF THE LITERATURE , 1972, Medicine.

[98]  J. Dobbie.  Adrenocortical nodular hyperplasia: The ageing adrenal , 1969, The Journal of pathology.

[99]  J. Kokko,et al.  Adrenal adenoma and hypertension. , 1967, Lancet.

[100]  P. Benson,et al.  Congenital hemihypertrophy and malignancy. , 1963, Lancet.

[101]  S. Sommers,et al.  A study of the adrenal status in hypertension. , 1958, Journal of chronic diseases.

[102]  H. Blumenthal,et al.  Small adenomas of the adrenal cortex in hypertension and diabetes. , 1945, Archives of internal medicine.

[103]  M. Terzolo,et al.  Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. , 1997, Hormone research.

[104]  M. Goldberg,et al.  Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1995, Radiology.

[105]  W. Young,et al.  Primary aldosteronism: diagnosis and treatment. , 1990, Mayo Clinic proceedings.

[106]  B. Naylor,et al.  Adrenal Masses in Oncologic Patients: Functional and Morphologic Evaluation , 1989 .

[107]  J. Richie,et al.  Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. , 1985, AJR. American journal of roentgenology.

[108]  M. Lewandowska,et al.  [Adrenal cortical adenomas and hypertension]. , 1967, Polskie Archiwum Medycyny Wewnetrznej.

[109]  R. Commons,et al.  Adenomas of the adrenal cortex. , 1948, Archives of internal medicine.